Enanta Pharma loses appeal in Pfizer Paxlovid patent case
Go back to Enanta Pharma loses appeal in Pfizer Paxlovid patent case| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 12.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.95 | 52 Week High | $34.49 | |||
| Open | $12.95 | 52 Week Low | $20.39 | |||
| Day High | $12.95 | P/E | N/A | |||
| Day Low | $12.95 | EPS | $-3.18 | |||
| Volume | 233 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.01 | 52 Week High | $37.39 | |||
| Open | $25.01 | 52 Week Low | $28.25 | |||
| Day High | $25.01 | P/E | 15.16 | |||
| Day Low | $25.01 | EPS | $1.65 | |||
| Volume | 94,020 | |||||
